Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
Go back to Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 0.78 +0.04 (5.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.74 | 52 Week High | $9.58 | |||
| Open | $0.76 | 52 Week Low | $2.34 | |||
| Day High | $0.80 | P/E | N/A | |||
| Day Low | $0.74 | EPS | $-0.34 | |||
| Volume | 304,826 | |||||
